Sitryx Therapeutics
- Website
- sitryx.com
- Total Funding
- $99.0M
- Last Round
- $39.0M Series BJul 2022
- Rounds
- 3
About
Itaconate metabolism for inflammatory and autoimmune diseases
Summary
It has raised $99.0M in total across 3 rounds, most recently a $39.0M Series B round in Jul 2022. Investors include SV Health Investors, Sofinnova Partners and Oxford Science Enterprises.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
$39.0M
Jul 2022
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.